Latuda and Neupro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Latuda (lurasidone hydrochloride) and Neupro (rotigotine). Common drug interactions include dyspnoea among females and acute respiratory failure among males.

The phase IV clinical study analyzes what interactions people have when they take Latuda and Neupro. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Latuda?

Latuda has active ingredients of lurasidone hydrochloride. It is often used in bipolar disorder. eHealthMe is studying from 21,543 Latuda users. Check the latest studies of Latuda.

What is Neupro?

Neupro has active ingredients of rotigotine. It is often used in parkinson's disease. eHealthMe is studying from 11,393 Neupro users. Check the latest studies of Neupro.

On Jul, 05, 2026

15 people who take Latuda and Neupro together, and have interactions are studied.

What are the common drug interactions of Latuda and Neupro, by gender? *:

female:

Dyspnoea (difficult or laboured respiration)
Heart rate increased
Hunger
Insomnia (sleeplessness)
Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
Sleep paralysis (waking up and unable to move or speak)
Snoring
Weight increased
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety

male:

Acute respiratory failure
Blood pressure systolic increased
Nephrolithiasis (calculi in the kidneys)
Weight increased
Coma (state of unconsciousness lasting more than six hours)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Encephalopathy (functioning of the brain is affected by some agent or condition)
Haematemesis (vomiting of blood)
Arthralgia (joint pain)
Compulsive shopping

What are the common drug interactions of Latuda and Neupro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Hospitalisation
Arthralgia (joint pain)
Compulsive shopping
Eating disorder
Nephrolithiasis (calculi in the kidneys)
Weight increased

40-49:

Drug withdrawal headache
Headache (pain in head)
Phonophobia (a morbid fear of sounds including your own voice)
Photophobia (extreme sensitivity to light)

50-59:

Dyspnoea (difficult or laboured respiration)
Dysuria (painful or difficult urination)
Fatigue (feeling of tiredness)
Heart rate increased
Hunger
Insomnia (sleeplessness)
Merycism (a rare disease in which food is chewed, swallowed, and then returned to the mouth and chewed again)
Muscle spasms (muscle contraction)
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)

60+:

Akathisia (a movement disorder characterized by a feeling of inner restlessness)
Fall
Fracture
Restlessness (not able to rest)
Therapeutic response decreased (less preventive response)

What are the existing conditions these people have? *

Stress And Anxiety: 5 people, 33.33%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 33.33%
Pain: 4 people, 26.67%
Nausea (feeling of having an urge to vomit): 4 people, 26.67%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 26.67%
Depression: 4 people, 26.67%
High Blood Cholesterol: 4 people, 26.67%
Insomnia (sleeplessness): 3 people, 20.00%
Sleep Disorder: 3 people, 20.00%
Fever: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Latuda and Neupro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously